In Spain, whole cell pertussis vaccination started in 1975, with three doses before the age of
6-7 months. Doses at 15-18 months and 4-6 years were introduced in 1996 and 2001 …

Background. We conducted a 5-year follow-up study on the persistence of pertussis-specific
antibody and cell-mediated immunity after booster immunization of adolescents aged 11–13 …

The introduction of acellular pertussis (Pa) vaccines in countries with a low uptake of whole-
cell pertussis (Pw) vaccines has led to a dramatic reduction in pertussis disease. Diphtheria …

Pertussis remains a public health concern in many countries despite high vaccination
coverage rates. Nosocomial outbreaks of pertussis continue to occur in neonatal units …

Background: Adult formulation tetanus and diphtheria toxoids and acellular pertussis
vaccines (Tdap) have been developed to prevent pertussis in adolescents and adults. There …

Pertussis, or “whooping cough,” caused by the gram-negative pleomorphic bacillus
Bordetella pertussis, is a highly contagious, potentially life-threatening respiratory tract …

Whooping cough, caused by B. pertussis and B. parapertussis, has increased in incidence
throughout much of the developed world since the 1980s despite high vaccine coverage …

Pertussis is a worldwide infectious disease which persists despite massive vaccination
campaigns that have gone on for several decades. To obtain an overall view of pertussis …

Background The incidence of reported adolescent and adult pertussis continues to rise in
the United States. Acellular pertussis vaccines for adolescents and adults have been …

This study aims to use big data (climate data, internet query data and school calendar
patterns (SCP)) to improve pertussis surveillance and prediction, and develop an early …